Substrates for peptidase C03.021: rhinovirus picornain 2A
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| eukaryotic translation initiation factor 4 gamma 1 | Q04637 | 1-1599 | peptide-Arg486+Gly-peptide | N | Leu | Ser | Thr | Arg | Gly | Pro | Pro | Arg | Gradi et al., 2004 | 20484 | ||
| eukaryotic translation initiation factor 4 gamma 3 | O43432 | 1-1585 | peptide-Val699+Gly-peptide | N | Leu | Leu | Asn | Val | Gly | Ser | Arg | Arg | Gradi et al., 2003 | 16167 | ||
| eukaryotic translation initiation factor 4 gamma 3 | O43432 | 1-1585 | peptide-Arg692+Gly-peptide | N | Pro | Gly | Gly | Arg | Gly | Val | Pro | Leu | Gradi et al., 2004 | 20486 | ||
| karatin, type II cytoskeletal 8 | P05787 | 2-483 | peptide-Ser14+Gly-peptide | N | Val | Ser | Thr | Ser | Gly | Pro | Arg | Ala | Skern, 2004 | 16165 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Thr102+Ala-peptide | N | NT | Leu | Ser | Asn | Thr | Ala | Ala | Thr | Pro | Park et al., 2010 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Thr217+Gly-peptide | N | NT | Ile | Thr | Ser | Thr | Gly | Pro | Ser | Leu | Park et al., 2010 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Ala246+Gly-peptide | N | NT | Val | Thr | Thr | Ala | Gly | Ala | Pro | Thr | Park et al., 2010 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Leu297+Ala-peptide | N | NT | Leu | Lys | Pro | Leu | Ala | Pro | Ala | Gly | Park et al., 2010 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Ala176+Gly-peptide | N | CS | Ile | Gly | Ser | Ala | Gly | Asn | Ser | Ala | Park et al., 2010 | ||
| nuclear pore glycoprotein p62 | P37198 | 1-522 | peptide-Ala200+Gly-peptide | N | CS | Ala | Thr | Thr | Ala | Gly | Ala | Thr | Gln | Park et al., 2010 | ||
| polyprotein | P04936 | 2-2150 | peptide-Tyr856+Val-peptide | P | Ser | Asp | Met | Tyr | Val | His | Val | Gly | Skern, 2004 | 16169 | ||
| polyprotein | P04936 | 2-2150 | peptide-Ala849+Gly-peptide | P | Ile | Thr | Thr | Ala | Gly | Pro | Ser | Asp | Skern, 2004 | 16168 |
